These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1773314)
1. Relationship between blood transfusion and tumour behaviour. Francis DM Br J Surg; 1991 Dec; 78(12):1420-8. PubMed ID: 1773314 [TBL] [Abstract][Full Text] [Related]
2. Blood transfusion and recurrence of cancer of the colon and rectum. Francis DM; Judson RT Br J Surg; 1987 Jan; 74(1):26-30. PubMed ID: 3828731 [TBL] [Abstract][Full Text] [Related]
3. Blood transfusion and tumour growth: an experimental study. Judson RT; Robb L; D'Apice AJ Aust N Z J Surg; 1985 Oct; 55(5):503-6. PubMed ID: 3868416 [TBL] [Abstract][Full Text] [Related]
8. Blood transfusion and recurrence of colorectal cancer: the role of platelet derived growth factors. Lawrance RJ; Cooper AJ; Loizidou M; Alexander P; Taylor I Br J Surg; 1990 Oct; 77(10):1106-9. PubMed ID: 2224457 [TBL] [Abstract][Full Text] [Related]
9. Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence. Weiden PL; Bean MA; Schultz P Cancer; 1987 Aug; 60(4):870-4. PubMed ID: 3594405 [TBL] [Abstract][Full Text] [Related]
10. Immunologic effects of blood transfusion. Tartter PI Immunol Invest; 1995; 24(1-2):277-88. PubMed ID: 7713588 [TBL] [Abstract][Full Text] [Related]
11. [Suggestions on the control and stimulation of cellular immunity in cancer]. Hartenbach Chirurg; 1978 Nov; 49(11):695-8. PubMed ID: 82503 [TBL] [Abstract][Full Text] [Related]
12. Transfusion and host defenses against cancer recurrence and infection. Blumberg N; Heal JM Transfusion; 1989; 29(3):236-45. PubMed ID: 2646766 [No Abstract] [Full Text] [Related]
13. Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Blumberg N; Heal J; Chuang C; Murphy P; Agarwal M Ann Surg; 1988 Apr; 207(4):410-5. PubMed ID: 3355265 [TBL] [Abstract][Full Text] [Related]
14. Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness. Roelen DL; Dover EL; Niimi M; Young NT; Morris PJ; Wood KJ Eur J Immunol; 1996 Jul; 26(7):1468-74. PubMed ID: 8766548 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic transfusion and infection: economic and clinical implications. Blumberg N Semin Hematol; 1997 Jul; 34(3 Suppl 2):34-40. PubMed ID: 9253782 [TBL] [Abstract][Full Text] [Related]
16. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. Heiss MM; Mempel W; Delanoff C; Jauch KW; Gabka C; Mempel M; Dieterich HJ; Eissner HJ; Schildberg FW J Clin Oncol; 1994 Sep; 12(9):1859-67. PubMed ID: 8083709 [TBL] [Abstract][Full Text] [Related]
18. The relationship of immune status to the efficacy of immunotherapy in preventing tumour recurrence in mice. Levy JG; Whitney RB; Smith AG; Panno L Br J Cancer; 1974 Oct; 30(4):289-96. PubMed ID: 4447774 [TBL] [Abstract][Full Text] [Related]
20. Effect of allogeneic blood transfusions on the growth of two different tumours in the rat. Rössler W; Dreikorn K; Lenhard V; Zeller WJ; Scholler P Urol Int; 1985; 40(4):217-9. PubMed ID: 4049579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]